Manifold Partners’s Celgene Corp CELG Stock Holding History

Manifold Partners’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-5,910	Closed	-$708K	–	105
2015 Q4	$708K	Hold	5,910	–	–	0.63%	17
2015 Q3	$639K	Buy	+5,910	New	+$733K	0.6%	18
2013 Q4	–	Sell	-2,000	Closed	-$154K	–	165
2013 Q3	$154K	Sell	2,000 -500	-20%	-$35K	0.1%	55
2013 Q2	$146K	Buy	+2,500	New	+$150K	0.1%	62

Other funds holding CELG

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Manifold Partners's CELG Position: Q1 2016 in Review

Manifold Partners sold out of Celgene Corp (CELG) in Q1 2016, closing a stake of 5,910 shares — an estimated $708K sold.

Manifold Partners first reported a position in CELG in Q2 2013 and held it in 4 quarters. The position peaked at $708K in Q4 2015. 1,225 funds tracked by Wall St. Rank hold CELG as of Q1 2016.

Manifold Partners reported no remaining Celgene Corp position as of Q1 2016 after selling out during the quarter.
Manifold Partners sold 5,910 Celgene Corp shares in Q1 2016, an estimated $708K.
Manifold Partners first reported a position in Celgene Corp in Q2 2013 and held it in 4 quarters.
Manifold Partners's Celgene Corp position peaked at $708K in Q4 2015.
1,225 funds tracked by Wall St. Rank held Celgene Corp as of Q1 2016.

Based on Manifold Partners's 13F filing for Q1 2016, filed 2 Jun 2016.